Caterina Marchiò

Tissue arrays as fiducial markers for section alignment in 3‐D reconstruction technology

G Bussolati, Caterina Marchiò, M Volante, 2005, Journal of cellular and molecular medicine.

SF3B1 mutations constitute a novel therapeutic target in breast cancer

Caterina Marchiò, Jorge S Reis-Filho, Anna Sapino, 2014, The Journal of pathology.

PPM1D Is a Potential Therapeutic Target in Ovarian Clear Cell Carcinomas

Marketa Zvelebil, Alan Mackay, Alan Ashworth, 2009, Clinical Cancer Research.

Pleomorphism of the nuclear envelope in breast cancer: a new approach to an old problem

Caterina Marchiò, Gianni Bussolati, Anna Sapino, 2007, Journal of cellular and molecular medicine.

Tumour Heterogeneity of Breast Cancer: From Morphology to Personalised Medicine

Emad A. Rakha, Ian O. Ellis, Michel E. Vandenberghe, 2018, Pathobiology.

Search for Neuro-Endocrine Markers (Chromogranin A, Synaptophysin and VGF) in Breast Cancers. An integrated Approach Using Immunohistochemistry and Gene Expression Profiling

Enzo Medico, Nelson Rangel, Caterina Marchiò, 2013, Endocrine Pathology.

Differences and homologies of chromosomal alterations within and between breast cancer cell lines: a clustering analysis

Cristina Botta, Nelson Rangel, Caterina Marchiò, 2014, Molecular Cytogenetics.